Diseases of the Nervous System, Phase I
Imaging pancreatic beta-cells with PET neuroimaging agent 11C-PHNO
Volunteers
Health Professionals
What is the purpose of this trial?
We are conducting a PET imaging study to develop a way to measure the number of insulin secreting cells in the pancreas. This study is intended for people diagnosed with Type 2 Diabetes who are otherwise in good physical health and well controlled on insulin. The study requires 2-3 visits over several weeks.
- Trial withYale University School of Medicine and National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
- Ages18 years - 65 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated02/22/2024
- Study HIC#2000021287